Search
Selected Filter
Displaying 211–217 of 217 research results
-
The FDA's Indispensible Role (a guest blog from Dr. Patricia Zilliox)
While it may not seem obvious, the FDA ultimately drives everything — the researchers and the money. That’s because without FDA approval, you have no treatment, even if you have great research and adequate funding.
-
There's More Than One Way to Correct a Genetic Defect
A quick primer on genes and their critical role in building proteins.
-
Vision Testing and Retinal Imaging in Clinical Trials: What Patients Can Expect
Because measuring changes is not always easy, people in clinical trials often undergo a number of different tests over one or several years. It can be challenging for the patient, but is necessary to determine if a treatment is working.
-
The Importance of Stem Cells (a guest post from Dr. David Gamm)
Dr. David Gamm on the potential of stem cell research to benefit patients with retinal degenerations.
-
The Foundation's 5 Most Asked Questions About Clinical Trials
What you need to know (and what to expect) about clinical trials.
-
Gene Therapy Revives Cones Long After They Stop Working
A Foundation-funded research group is developing a gene therapy that revives degenerating cones, enabling them to regain their ability to respond to light and provide vision.
-
The study is designed to evaluate the pharmacodynamics, safety and tolerability of emixustat in subjects with macular atrophy secondary to Stargardt disease.
- Previous page
- page 1
- page 20
- page 21
- page 22
